文献速递心脑血管急症重症综合管理与镇静镇痛

连续流左心室辅助装置患者感染后卒中风险

Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device.
PubMed 文献 · Neurocrit Care · 2019-01-01
一句话结论单中心数据显示,左心室辅助装置(LVAD)感染患者中13%在感染后中位4天发生卒中,血培养阳性(BSI)与出血性卒中及更低的累积生存率显著相关。

该研究回顾性分析单中心402例HeartMate II(N=332)和HeartWare(N=70)LVAD患者的队列数据,评估LVAD感染(伤口、泵袋、驱动缆和/或血流感染)与感染后6周内缺血性或出血性卒中的关联。158例(39%)发生LVAD感染,其中20/158(13%)在感染后中位4天(0-36天)内发生卒中。多因素分析显示缺血性卒中与伤口感染(aOR 9.0,95%CI 2.4-34.0,P=0.001)和BSI(aOR 7.7,95%CI 0.9-66.0,P=0.064)相关,出血性卒中100%与BSI相关(P=0.01)。感染相关卒中患者累积生存率显著低于无卒中的LVAD感染患者(log-rank P<0.001)。

要点

  • LVAD感染患者中13%(20/158)在感染后6周内发生卒中,中位时间4天(0-36天)。
  • 缺血性卒中与伤口感染显著相关(aOR 9.0,95%CI 2.4-34.0,P=0.001),与BSI的关联未达统计学显著(aOR 7.7,95%CI 0.9-66.0,P=0.064)。
  • 出血性卒中100%发生于BSI患者(P=0.01),驱动缆或泵袋感染与卒中无关联。
  • 感染相关卒中患者累积生存率显著低于LVAD感染无卒中患者(log-rank P<0.001)。
  • LVAD感染患者卒中无生存期有缩短趋势。

适用人群与场景

  • 单中心连续纳入的HeartMate II(N=332)和HeartWare(N=70)连续流LVAD患者,共402例。

诊断标准与关键阈值

  • 仅分析LVAD感染后6周内发生的缺血性或出血性卒中。
  • LVAD感染包括伤口感染、泵袋感染、驱动缆感染和/或血流感染(BSI)。

红旗征与不能漏的情况

  • LVAD患者出现伤口感染时缺血性卒中风险显著升高(aOR 9.0,95%CI 2.4-34.0,P=0.001)。
  • LVAD患者出现血流感染(BSI)时出血性卒中风险显著升高(出血性卒中100%与BSI相关,P=0.01)。

研究设计与关键结果

  • 研究类型为单中心前瞻性收集数据的回顾性分析,样本量402例(HeartMate II N=332,HeartWare N=70)。
  • LVAD感染发生158例(39%),其中BSI 107例(27%)、驱动缆感染67例(17%)、伤口感染31例(8%)、泵袋感染24例(6%)。
  • 感染相关卒中发生20/158例(13%),中位时间4天(0-36天)。
  • 多因素分析:缺血性卒中与伤口感染相关(aOR 9.0,95%CI 2.4-34.0,P=0.001),与BSI关联未达统计学显著(aOR 7.7,95%CI 0.9-66.0,P=0.064)。
  • 出血性卒中100%发生于BSI患者(P=0.01);驱动缆或泵袋感染与卒中无关联。
  • 感染相关卒中患者累积生存率显著低于LVAD感染无卒中患者(log-rank P<0.001)。
  • LVAD感染患者卒中无生存期有缩短趋势。

证据类型、等级与局限

  • 证据类型:单中心回顾性分析,前瞻性收集数据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对LVAD合并伤口感染或血流感染的患者,应警惕感染后6周内(尤其感染后数日内)发生卒中的可能。
  • LVAD感染相关卒中患者累积生存率显著更低,提示需加强此类患者的监测与救治。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Infection has been associated with stroke in patients with left ventricular assist devices (LVAD); however, little data exist on the timing, type and mortality impact of infection-related stroke.

METHODS: Prospectively collected data of HeartMate II (N = 332) and HeartWare (N = 70) LVAD patients from a single center were reviewed. Only strokes (ischemic or hemorrhagic) that occurred within 6 weeks following a LVAD infection were considered in analyses. The association between LVAD infections (wound, pump pocket, driveline and/or bloodstream infection [BSI]), specific pathogens and ischemic and hemorrhagic strokes was evaluated using multivariable logistic regression analysis. The impact of infection-related stroke on cumulative survival was assessed using Kaplan-Meier analysis.

RESULTS: Of 402 patients, LVAD infection occurred in 158 (39%) including BSI in 107 (27%), driveline infection in 67 (17%), wound infection in 31 (8%) and pump pocket infection in 24 (6%). LVAD infection-related stroke occurred in 20/158 (13%) patients in a median of 4 days (0-36 days) from documented infection. In multivariable analysis, ischemic stroke was associated with wound infection (aOR 9.0, 95% CI 2.4-34.0, P = 0.001) and BSI (aOR 7.7, 95% CI 0.9-66.0, P = 0.064), and hemorrhagic stroke was associated with BSI in 100% of cases (P = 0.01). There was no association with driveline or pump pocket infection. The cumulative survival rate among patients with infection-related stroke was significantly lower compared to those with LVAD infection but no stroke (log-rank P < 0.001). There was a trend toward shorter stroke-free survival among patients with LVAD infection.

CONCLUSIONS: LVAD infections, particularly BSI, are significantly associated with stroke, and infection-related stroke conferred significantly lower cumulative survival.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Cho SM, Moazami N, Katz S, et al. Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device. Neurocrit Care. 2019. PMID: 30644037. doi:10.1007/s12028-018-0662-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。